Learn more about whether BioMarin Pharmaceutical Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO ...

The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...

Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology has been licensed by Ginkgo ...

Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ...

The interstellar visitor 3I/ATLAS has become the latest flashpoint in a growing debate over how to interpret strange behavior ...

The insect repellent market is set for robust growth driven by rising vector-borne diseases and supportive government ...

The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

Doctoral Landscape Programme provides up to 18 fully funded PhD studentships available for October 2026. This programme will train students in interdisciplinary approaches to infection biosciences ...

Shares of Regencell Bioscience Holdings (RGC 3.24%) have been on quite a ride since their 2021 initial public offering (IPO), surging 9,800% year to date (as of Nov. 19). That's enough to drive many ...